Although many systemic immunomodulators are approved for psoriasis, their mechanisms of action suggest they have utility in indications ranging from atopic dermatitis (AD) to chronic urticaria. Understanding a systemic immunomodulator’s mechanism of action provides a theoretical basis for uses beyond its labeled indication.
To determine the utility of food allergy panel testing among patients referred to a pediatric food allergy center, investigators conducted a retrospective chart review of such patients for whom a primary care provider had obtained a standard panel of immunoglobulin E (IgE) tests.
There is increasing interest in so-called alternative medicine. Both patients and practitioners are clearly interested in this domain and this is in striking contrast to the bright, shining edifice of evidence-based medicine.
Dermatology Times editorial advisor, Elaine Siegfried, M.D., talks with Peter Lio, M.D., assistant professor of clinical dermatology and pediatrics at Northwestern University’s Feinberg School of Medicine, and private practice, Dermatology and Aesthetics of Wicker Park, Wicker Park, Chicago, about his interest in alternative medicine and the legitimacy and usefulness of certain techniques and therapies.
The advent of spring yields the annual pilgrimage of patients into our offices complaining of the itchy, watery eyes of allergy. As any eyecare practitioner can attest, ocular allergy is one of the most common presentations to an eyecare practice.
According to researchers, abnormalities in the skin barrier and in the immune system that characterize atopic dermatitis can be reversed by drugs that narrowly target the immune signaling proteins interleukin (IL)-4 and -13.
New topical and systemic medications are being developed specifically for atopic dermatitis (AD). New guidelines of care for the management of AD are being issued by the American Academy of Dermatology, and ongoing research in other areas may change the approach to AD management in the future. Meanwhile, strategies are needed to combat steroid phobia.
The bad news is that office visits for atopic dermatitis are on the rise; the good news is that the condition usually responds to topical therapy and vigilant skin care, according to a clinical report from the American Academy of Pediatrics.